拓胜医药完成4000万美元天使轮融资，本轮融资将全面支持研发管线稳步推进

Core Insights - Tosun Pharmaceutical, a biopharmaceutical innovation company founded by Professor Liu Yongjun, has completed a $40 million angel round financing [1] - The financing round was led by Qiji Investment and Jiadao Capital, with participation from several notable institutions including Hongning Hengtai, Betta Pharmaceuticals, Tigermed, and others [1] - The raised funds will primarily be used to advance the research and development of third-generation antibody-drug conjugates (ADCs), focusing on multi-target layouts, innovative design of differentiated payloads, and the development of oncology pipelines [1]